SUBSCRIBE
SUBSCRIBE

ArsenalBio

NEWS
Justin Sullivan/Getty Images
Business
Genentech Teams Up with ArsenalBio in Cell Therapy Partnership (Updated)
Genentech and privately-held Arsenal Biosciences forged a multi-year collaboration to identify critical success circuits in T cell-based therapies for solid tumors.
September 28, 2022
 · 
3 min read
 · 
Alex Keown
Deals
Biopharma Executive Perspectives on 2022
BioSpace sat down with 12 executives who shared their thoughts on the coming year and decade.
January 8, 2022
 · 
11 min read
 · 
Heather McKenzie
Business
BioSpace Movers & Shakers, July 23
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
July 22, 2021
 · 
7 min read
 · 
Alex Keown
Courtesy nitpicker/Shutterstock
Business
BMS Kicks Off 2021 with $70 Million Collab for Next-Gen T Cell Cancer Therapies
ArsenalBio has entered into a multi-year discovery partnership with Bristol Myers Squibb to develop next-generation T cell therapies for solid tumors.
January 7, 2021
 · 
3 min read
 · 
Brandon May
Look at these top life science startups.
Pharm Country
Top Life Science Startups to Watch in 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.
January 5, 2021
 · 
16 min read
 · 
Mark Terry
AWARDS
  • NextGen Class of 2021
JOBS
IN THE PRESS
Press Releases
ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors
January 14, 2025
 · 
3 min read
Press Releases
ArsenalBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
 · 
1 min read
Press Releases
Nate Hardy to Join Arsenal Biosciences, Inc. as Chief Financial Officer
September 16, 2024
 · 
2 min read
Drug Development
Arsenal Biosciences Announces First Patient Dosed in Phase 1/2 Clinical Trial of AB-2100 in Development as a Treatment for Clear-cell Renal Cell Carcinoma
April 30, 2024
 · 
3 min read
Drug Development
ArsenalBio Announces First Patient Dosed in Phase 1 Clinical Trial of AB-1015 in Development as a Treatment for Ovarian Cancer
January 5, 2023
 · 
3 min read
Biotech Bay
ArsenalBio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
January 4, 2022
 · 
1 min read
Biotech Bay
ArsenalBio to Participate in Upcoming Investor Conferences
November 19, 2021
 · 
1 min read
Biotech Bay
ArsenalBio Announces Participation in Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
November 4, 2021
 · 
2 min read
Business
ArsenalBio Announces Appointment of John Schroer as Chief Financial Officer and Tim Sirichoke as Chief Technical Operations Officer
March 8, 2021
 · 
4 min read
Business
ArsenalBio Announces Multi-Program Discovery Collaboration with Bristol Myers Squibb to Advance Next-Generation T cell Therapies for Solid Tumors
January 7, 2021
 · 
2 min read